sanguinarine has been researched along with Disease Models, Animal in 15 studies
benzophenanthridine alkaloid : A specific group of isoquinoline alkaloids that occur only in higher plants and are constituents mainly of the Papaveraceae family.
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sanguinarine (SG) is a natural plant medicine with anti-inflammatory and neuroprotection effects." | 5.56 | Sanguinarine Attenuates Neuropathic Pain by Inhibiting P38 MAPK Activated Neuroinflammation in Rat Model. ( Li, P; Liang, LS; Wang, YX; Yu, C; Zhang, KG; Zheng, ZC, 2020) |
| " Ethanol-induced gastric ulcer model was performed on Kunming mice to examine the anti-inflammatory activity of SG-SLNs and compare it with sanguinarine (SG)." | 3.85 | Preparation, Characterization and Anti-Ulcer Efficacy of Sanguinarine Loaded Solid Lipid Nanoparticles. ( Li, H; Li, W; Niu, X; Sun, Q; Wang, X; Wang, Y, 2017) |
| "We investigated the antidepressant effects of bilateral intra-the ventrolateral orbital cortex (VLO) administration of sanguinarine (SA), a selective mitogen-activated protein kinase phosphatase-1 (Mkp-1) inhibitor, in rats that had been subjected to a forced swimming test (FST) which is a classic animal model of depression." | 3.78 | Microinjection of sanguinarine into the ventrolateral orbital cortex inhibits Mkp-1 and exerts an antidepressant-like effect in rats. ( Chen, Y; Peng, Z; Sun, R; Tan, Q; Wang, H; Zhang, R, 2012) |
| "The ergosterol pathway is a prime antifungal target as it is required for fungal survival, yet is not involved in human homeostasis." | 1.62 | Plant-derived isoquinoline alkaloids that target ergosterol biosynthesis discovered by using a novel antifungal screening tool. ( Deyrup, ST; He, ZD; Liu, XB; Ng, TW; Qing, ZX; Song, X; Wong-Deyrup, SW; Zeng, JG; Zhang, HJ, 2021) |
| "Sanguinarine is a natural plant medicine with anti-inflammatory effects, but its effect on neuropathic pain remains unclear." | 1.62 | Sanguinarine Attenuates Neuropathic Pain in a Rat Model of Chronic Constriction Injury. ( Li, P; Wang, YX; Yang, G; Yu, C; Zheng, ZC, 2021) |
| "Sanguinarine is a benzophenanthridine alkaloid that has biological activity, such as antibacterial, antitumour and antiparasitic activities." | 1.56 | Sanguinarine has anthelmintic activity against the enteral and parenteral phases of trichinella infection in experimentally infected mice. ( Huang, H; Jiang, Y; Kang, Y; Liu, K; Shi, C; Wang, C; Wang, D; Wang, G; Wang, J; Yang, G; Yang, W; Yao, J, 2020) |
| "Sanguinarine (SG) is a natural plant medicine with anti-inflammatory and neuroprotection effects." | 1.56 | Sanguinarine Attenuates Neuropathic Pain by Inhibiting P38 MAPK Activated Neuroinflammation in Rat Model. ( Li, P; Liang, LS; Wang, YX; Yu, C; Zhang, KG; Zheng, ZC, 2020) |
| "Sanguinarine treatment (0." | 1.48 | Anti-osteoporosis activity of Sanguinarine in preosteoblast MC3T3-E1 cells and an ovariectomized rat model. ( Wang, G; Xie, J; Yang, H; Zhang, F; Zhang, G, 2018) |
| "The sanguinarine (SG) was studied for its pharmacokinetic and anti-inflammatory activities with prepared solid lipid nanoparticles (SLNs)." | 1.40 | Pharmacokinetic and anti-inflammatory effects of sanguinarine solid lipid nanoparticles. ( Hu, H; Li, H; Li, W; Li, Y; Mu, Q; Niu, X; Yao, H; Zhao, G, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (60.00) | 24.3611 |
| 2020's | 6 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Solinski, HJ | 1 |
| Dranchak, P | 1 |
| Oliphant, E | 1 |
| Gu, X | 1 |
| Earnest, TW | 1 |
| Braisted, J | 1 |
| Inglese, J | 1 |
| Hoon, MA | 1 |
| Abrams, RPM | 1 |
| Yasgar, A | 1 |
| Teramoto, T | 1 |
| Lee, MH | 1 |
| Dorjsuren, D | 1 |
| Eastman, RT | 1 |
| Malik, N | 1 |
| Zakharov, AV | 1 |
| Li, W | 3 |
| Bachani, M | 1 |
| Brimacombe, K | 1 |
| Steiner, JP | 1 |
| Hall, MD | 1 |
| Balasubramanian, A | 1 |
| Jadhav, A | 1 |
| Padmanabhan, R | 1 |
| Simeonov, A | 1 |
| Nath, A | 1 |
| Li, B | 1 |
| Luo, Y | 1 |
| Zhou, Y | 1 |
| Wu, J | 1 |
| Fang, Z | 1 |
| Li, Y | 2 |
| Huang, H | 1 |
| Yao, J | 1 |
| Liu, K | 1 |
| Yang, W | 1 |
| Wang, G | 2 |
| Shi, C | 1 |
| Jiang, Y | 1 |
| Wang, J | 1 |
| Kang, Y | 1 |
| Wang, D | 1 |
| Wang, C | 1 |
| Yang, G | 2 |
| Yu, C | 2 |
| Li, P | 2 |
| Wang, YX | 2 |
| Zhang, KG | 1 |
| Zheng, ZC | 2 |
| Liang, LS | 1 |
| Wong-Deyrup, SW | 1 |
| Song, X | 1 |
| Ng, TW | 1 |
| Liu, XB | 1 |
| Zeng, JG | 1 |
| Qing, ZX | 1 |
| Deyrup, ST | 1 |
| He, ZD | 1 |
| Zhang, HJ | 1 |
| Sun, Q | 1 |
| Li, H | 2 |
| Wang, X | 1 |
| Wang, Y | 1 |
| Niu, X | 2 |
| Ma, Y | 1 |
| Chu, J | 1 |
| Ma, J | 1 |
| Ning, L | 1 |
| Zhou, K | 1 |
| Fang, X | 1 |
| Zhang, F | 1 |
| Xie, J | 1 |
| Zhang, G | 1 |
| Yang, H | 1 |
| Kikuchi, N | 1 |
| Satoh, K | 1 |
| Kurosawa, R | 1 |
| Yaoita, N | 1 |
| Elias-Al-Mamun, M | 1 |
| Siddique, MAH | 1 |
| Omura, J | 1 |
| Satoh, T | 1 |
| Nogi, M | 1 |
| Sunamura, S | 1 |
| Miyata, S | 1 |
| Saito, Y | 1 |
| Hoshikawa, Y | 1 |
| Okada, Y | 1 |
| Shimokawa, H | 1 |
| Yao, H | 1 |
| Mu, Q | 1 |
| Zhao, G | 1 |
| Hu, H | 1 |
| Leung, EL | 1 |
| Fan, XX | 1 |
| Wong, MP | 1 |
| Jiang, ZH | 1 |
| Liu, ZQ | 1 |
| Yao, XJ | 1 |
| Lu, LL | 1 |
| Zhou, YL | 1 |
| Yau, LF | 1 |
| Tin, VP | 1 |
| Liu, L | 1 |
| Ansari, KM | 1 |
| Das, M | 1 |
| Chen, Y | 1 |
| Wang, H | 2 |
| Zhang, R | 1 |
| Peng, Z | 1 |
| Sun, R | 1 |
| Tan, Q | 1 |
15 other studies available for sanguinarine and Disease Models, Animal
| Article | Year |
|---|---|
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, S | 2019 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr | 2020 |
Role of sanguinarine in regulating immunosuppression in a Lewis lung cancer mouse model.
Topics: Animals; Benzophenanthridines; Carcinoma, Lewis Lung; Disease Models, Animal; Immunosuppression Ther | 2022 |
Sanguinarine has anthelmintic activity against the enteral and parenteral phases of trichinella infection in experimentally infected mice.
Topics: Animals; Anthelmintics; Benzophenanthridines; Disease Models, Animal; Intestine, Small; Isoquinoline | 2020 |
Sanguinarine Attenuates Neuropathic Pain by Inhibiting P38 MAPK Activated Neuroinflammation in Rat Model.
Topics: Animals; Anti-Inflammatory Agents; Benzophenanthridines; Constriction; Disease Models, Animal; Dose- | 2020 |
Plant-derived isoquinoline alkaloids that target ergosterol biosynthesis discovered by using a novel antifungal screening tool.
Topics: Alkaloids; Animals; Antifungal Agents; Arthrodermataceae; Benzophenanthridines; Disease Models, Anim | 2021 |
Sanguinarine Attenuates Neuropathic Pain in a Rat Model of Chronic Constriction Injury.
Topics: Animals; Benzophenanthridines; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; | 2021 |
Preparation, Characterization and Anti-Ulcer Efficacy of Sanguinarine Loaded Solid Lipid Nanoparticles.
Topics: Animals; Anti-Ulcer Agents; Benzophenanthridines; Chemistry, Pharmaceutical; Disease Models, Animal; | 2017 |
Sanguinarine protects against ovariectomy‑induced osteoporosis in mice.
Topics: Animals; Benzophenanthridines; Bone and Bones; Bone Remodeling; Disease Models, Animal; Female; Isoq | 2017 |
Anti-osteoporosis activity of Sanguinarine in preosteoblast MC3T3-E1 cells and an ovariectomized rat model.
Topics: 3T3 Cells; AMP-Activated Protein Kinases; Animals; Benzophenanthridines; Bone Density; Bone Density | 2018 |
Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target.
Topics: Animals; Antihypertensive Agents; Apoptosis; Arterial Pressure; Benzophenanthridines; Cell Prolifera | 2018 |
Pharmacokinetic and anti-inflammatory effects of sanguinarine solid lipid nanoparticles.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Benzophenanthridines; Biological Availabili | 2014 |
Targeting Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer by Inducing Epidermal Growth Factor Receptor Degradation via Methionine 790 Oxidation.
Topics: Animals; Apoptosis; Benzophenanthridines; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Disease | 2016 |
Potentiation of tumour promotion by topical application of argemone oil/isolated sanguinarine alkaloid in a model of mouse skin carcinogenesis.
Topics: Administration, Cutaneous; Animals; Benzophenanthridines; Disease Models, Animal; Female; Humans; Is | 2010 |
Microinjection of sanguinarine into the ventrolateral orbital cortex inhibits Mkp-1 and exerts an antidepressant-like effect in rats.
Topics: Animals; Antidepressive Agents; Benzophenanthridines; Blotting, Western; Cerebral Cortex; Depression | 2012 |